| 【英語タイトル】Global Minimally Invasive Neurosurgical Devices Market Size study & Forecast, by Product (Surgical Devices, Monitoring and Visualization Devices, Endoscopy Devices), by Surgery Type (Endonasal Neurosurgery, Intracranial, Spinal Surgery), by End-Use (Hospital & Clinics, Medical Institution, Ambulatory Surgical Center) and Regional Analysis, 2022-2029
|
 | ・商品コード：BZW23MA086
・発行会社（調査会社）：Bizwit Research & Consulting
・発行日：2023年4月17日
・ページ数：約200
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野：医療
|
◆販売価格オプション
（消費税別）
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
|
❖ レポートの概要 ❖
Bizwit Research社の本調査資料では、2021年にXX百万ドルであった世界の低侵襲神経手術装置市場規模が、2022年〜2029年にかけて年平均XX%で成長すると予測しています。本資料は、低侵襲神経手術装置の世界市場について市場実態を明らかにするとともに、今後の動向を展望したレポートです。エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、製品別（手術装置、監視・可視化装置、内視鏡検査装置）分析、手術別（鼻腔内脳神経手術、頭蓋内手術、脊髄手術）分析、エンドユーザー別（病院・診療所、医療機関、外来手術センター）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他地域）分析、競争分析、調査プロセスなどの項目で構成されています。また、主要参入企業として、General Medical Inc. 、Stryker、 Zimmer Biomet、 B. Braun Melsungen AG、Olympus Corporation、 Renishaw Plc.、 Medtronic、 Danaher、Zeiss、 Karl Storz SE & Co. KGなどの情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界の低侵襲神経手術装置市場規模：製品別
- 手術装置の市場規模
- 監視・可視化装置の市場規模
- 内視鏡検査装置の市場規模
・世界の低侵襲神経手術装置市場規模：手術別
- 鼻腔内脳神経手術における市場規模
- 頭蓋内手術における市場規模
- 脊髄手術における市場規模
・世界の低侵襲神経手術装置市場規模：エンドユーザー別
- 病院・診療所における市場規模
- 医療機関における市場規模
- 外来手術センターにおける市場規模
・世界の低侵襲神経手術装置市場規模：地域別
- 北米の低侵襲神経手術装置市場規模
- ヨーロッパの低侵襲神経手術装置市場規模
- アジア太平洋の低侵襲神経手術装置市場規模
- 中南米の低侵襲神経手術装置市場規模
- その他地域の低侵襲神経手術装置市場規模
・競争分析
・調査プロセス |
Global Minimally Invasive Neurosurgical Devices Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Minimally invasive neurosurgical devices are those utilized in neurosurgery. With the aid of this device, healing time is quickened, and the size of the required incision is constrained. These instruments are frequently created and used by neurosurgery specialists and are normally relatively small for extremely precise surgeries. Minimally invasive neurosurgical devices are any less traumatic method than open surgery used for the same purpose, and they are redefining surgery. In minimally invasive neurosurgery (MIS) procedures, which assess the operating field on a micro- or endoscopic scale, laparoscopic equipment and remote controls for surgical tools are routinely used. The increasing prevalence of neurological disorders and growing geriatric population are key factors driving the market growth.
As the world’s population ages and more neurological illnesses are diagnosed, the cost of mortality and impairment brought on by these conditions is being increasingly acknowledged as a worldwide public health concern. For instance – as per Pan American Health Organization (PAHO) – in 2019 people died because of neurological disorders accounted for 533,172, with 320,043 (60%) women and 213,129 (40%) men. Age-standardized mortality rates were 32.9 per 100,000 people, with 33.1 deaths per 100,000 people for males and 32.2 for women. The United States of America has the highest age-standardized death rate (47.4 deaths per 100,000 people), while Venezuela has the lowest rate (6.6 deaths per 100,000 population). Furthermore, according to the World Bank Group, the world’s old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Also, increasing incidence of vascular disorders increases and growing number of neurosurgical procedures would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Minimally Invasive Neurosurgical Devices and procedures stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Minimally Invasive Neurosurgical Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the rising prevalence of neurovascular diseases and also the growing awareness among neurosurgeons and doctors regarding the benefits of these neurology devices. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, increasing prevalence of neurological conditions as well as growing expansion of healthcare services in the region.
Major market players included in this report are:
General Medical Inc.
Stryker
Zimmer Biomet
B. Braun Melsungen AG
Olympus Corporation
Renishaw Plc.
Medtronic
Danaher
Zeiss
Karl Storz SE & Co. KG
Recent Developments in the Market:
In September 2022, Brainlab announced the acquisition of Waldkrich, Germany based Dr. Langer Medical GmbH. The family-owned company specializes in the development of intraoperative neuromonitoring solutions and related equipment for surgical interventions.
Global Minimally Invasive Neurosurgical Devices Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Surgery Type, End-Use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product
Surgical Devices
Monitoring and Visualization Devices
Endoscopy Devices
By Surgery Type
Endonasal Neurosurgery
Intracranial
Spinal Surgery
By End-Use
Hospital & Clinics
Medical Institution
Ambulatory Surgical Center
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Minimally Invasive Neurosurgical Devices Market, by Region, 2019-2029 (USD Million)
1.2.2. Minimally Invasive Neurosurgical Devices Market, by Product, 2019-2029 (USD Million)
1.2.3. Minimally Invasive Neurosurgical Devices Market, by Surgery Type, 2019-2029 (USD Million)
1.2.4. Minimally Invasive Neurosurgical Devices Market, by End-Use, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Minimally Invasive Neurosurgical Devices Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Minimally Invasive Neurosurgical Devices Market Dynamics
3.1. Minimally Invasive Neurosurgical Devices Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of neurological disorders
3.1.1.2. Growing Geriatric Population
3.1.2. Market Challenges
3.1.2.1. High Cost associated with Neurosurgical Devices
3.1.3. Market Opportunities
3.1.3.1. Increasing incidence of vascular disorders increases
3.1.3.2. Growing number of Neurosurgical Procedures
Chapter 4. Global Minimally Invasive Neurosurgical Devices Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Minimally Invasive Neurosurgical Devices Market, by Product
6.1. Market Snapshot
6.2. Global Minimally Invasive Neurosurgical Devices Market by Product, Performance – Potential Analysis
6.3. Global Minimally Invasive Neurosurgical Devices Market Estimates & Forecasts by Product 2019-2029 (USD Million)
6.4. Minimally Invasive Neurosurgical Devices Market, Sub Segment Analysis
6.4.1. Surgical Devices
6.4.2. Monitoring and Visualization Devices
6.4.3. Endoscopy Devices
Chapter 7. Global Minimally Invasive Neurosurgical Devices Market, by Surgery Type
7.1. Market Snapshot
7.2. Global Minimally Invasive Neurosurgical Devices Market by Surgery Type, Performance – Potential Analysis
7.3. Global Minimally Invasive Neurosurgical Devices Market Estimates & Forecasts by Surgery Type 2019-2029 (USD Million)
7.4. Minimally Invasive Neurosurgical Devices Market, Sub Segment Analysis
7.4.1. Endonasal Neurosurgery
7.4.2. Intracranial
7.4.3. Spinal Surgery
Chapter 8. Global Minimally Invasive Neurosurgical Devices Market, by End-Use
8.1. Market Snapshot
8.2. Global Minimally Invasive Neurosurgical Devices Market by End-Use, Performance – Potential Analysis
8.3. Global Minimally Invasive Neurosurgical Devices Market Estimates & Forecasts by End-Use 2019-2029 (USD Million)
8.4. Minimally Invasive Neurosurgical Devices Market, Sub Segment Analysis
8.4.1. Hospital & Clinics
8.4.2. Medical Institution
8.4.3. Ambulatory Surgical Centers
Chapter 9. Global Minimally Invasive Neurosurgical Devices Market, Regional Analysis
9.1. Minimally Invasive Neurosurgical Devices Market, Regional Market Snapshot
9.2. North America Minimally Invasive Neurosurgical Devices Market
9.2.1. U.S. Minimally Invasive Neurosurgical Devices Market
9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
9.2.1.2. Surgery Type breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-Use breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Minimally Invasive Neurosurgical Devices Market
9.3. Europe Minimally Invasive Neurosurgical Devices Market Snapshot
9.3.1. U.K. Minimally Invasive Neurosurgical Devices Market
9.3.2. Germany Minimally Invasive Neurosurgical Devices Market
9.3.3. France Minimally Invasive Neurosurgical Devices Market
9.3.4. Spain Minimally Invasive Neurosurgical Devices Market
9.3.5. Italy Minimally Invasive Neurosurgical Devices Market
9.3.6. Rest of Europe Minimally Invasive Neurosurgical Devices Market
9.4. Asia-Pacific Minimally Invasive Neurosurgical Devices Market Snapshot
9.4.1. China Minimally Invasive Neurosurgical Devices Market
9.4.2. India Minimally Invasive Neurosurgical Devices Market
9.4.3. Japan Minimally Invasive Neurosurgical Devices Market
9.4.4. Australia Minimally Invasive Neurosurgical Devices Market
9.4.5. South Korea Minimally Invasive Neurosurgical Devices Market
9.4.6. Rest of Asia Pacific Minimally Invasive Neurosurgical Devices Market
9.5. Latin America Minimally Invasive Neurosurgical Devices Market Snapshot
9.5.1. Brazil Minimally Invasive Neurosurgical Devices Market
9.5.2. Mexico Minimally Invasive Neurosurgical Devices Market
9.5.3. Rest of Latin America Minimally Invasive Neurosurgical Devices Market
9.6. Rest of The World Minimally Invasive Neurosurgical Devices Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. General Medical Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Stryker
10.2.3. Zimmer Biomet
10.2.4. B. Braun Melsungen AG
10.2.5. Olympus Corporation
10.2.6. Renishaw Plc.
10.2.7. Medtronic
10.2.8. Danaher
10.2.9. Zeiss
10.2.10. Karl Storz SE & Co. KG
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
